127 related articles for article (PubMed ID: 9314961)
1. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT.
Platt JF; Francis IR; Ellis JH; Reige KA
Radiology; 1997 Oct; 205(1):49-53. PubMed ID: 9314961
[TBL] [Abstract][Full Text] [Related]
2. Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases?
Sheafor DH; Killius JS; Paulson EK; DeLong DM; Foti AM; Nelson RC
Radiology; 2000 Mar; 214(3):875-80. PubMed ID: 10715061
[TBL] [Abstract][Full Text] [Related]
3. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms.
Hollett MD; Jeffrey RB; Nino-Murcia M; Jorgensen MJ; Harris DP
AJR Am J Roentgenol; 1995 Apr; 164(4):879-84. PubMed ID: 7726040
[TBL] [Abstract][Full Text] [Related]
4. Difference in global hepatic enhancement assessed by dynamic CT in normal subjects and patients with hepatic metastases.
Platt JF; Francis IR; Ellis JH; Reige KA
J Comput Assist Tomogr; 1997; 21(3):348-54. PubMed ID: 9135639
[TBL] [Abstract][Full Text] [Related]
5. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients.
Vignaux O; Legmann P; Coste J; Hoeffel C; Bonnin A
AJR Am J Roentgenol; 1999 Nov; 173(5):1193-7. PubMed ID: 10541087
[TBL] [Abstract][Full Text] [Related]
6. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.
Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M
AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695
[TBL] [Abstract][Full Text] [Related]
7. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns.
Leslie DF; Johnson CD; Johnson CM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Mar; 164(3):625-9. PubMed ID: 7863883
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer: value of dual-phase helical CT in assessing resectability.
Diehl SJ; Lehmann KJ; Sadick M; Lachmann R; Georgi M
Radiology; 1998 Feb; 206(2):373-8. PubMed ID: 9457188
[TBL] [Abstract][Full Text] [Related]
9. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
[TBL] [Abstract][Full Text] [Related]
10. Conspicuity of hepatic metastases on helical CT: effect of different time delays between contrast administration and scanning.
Silverman PM; O'Malley J; Tefft MC; Cooper C; Zeman RK
AJR Am J Roentgenol; 1995 Mar; 164(3):619-23. PubMed ID: 7863882
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT.
Tsurumaru D; Nishimuta Y; Muraki T; Asayama Y; Nishie A; Oki E; Honda H
Eur J Radiol; 2018 Nov; 108():165-171. PubMed ID: 30396650
[TBL] [Abstract][Full Text] [Related]
12. Comparison of unenhanced and contrast-enhanced spiral CT for assessing interval change in patients with colorectal liver metastases.
Park JH; Nazarian LN; Halpern EJ; Feld RI; Lev-Toaff AS; Parker L; Wechsler RJ
Acad Radiol; 2001 Aug; 8(8):698-704. PubMed ID: 11508748
[TBL] [Abstract][Full Text] [Related]
13. Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: how long does the hepatic arterial phase predominate?
Frederick MG; McElaney BL; Singer A; Park KS; Paulson EK; McGee SG; Nelson RC
AJR Am J Roentgenol; 1996 Jun; 166(6):1305-10. PubMed ID: 8633437
[TBL] [Abstract][Full Text] [Related]
14. Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma.
Sheafor DH; Frederick MG; Paulson EK; Keogan MT; DeLong DM; Nelson RC
AJR Am J Roentgenol; 1999 Apr; 172(4):961-8. PubMed ID: 10587129
[TBL] [Abstract][Full Text] [Related]
15. Hypervascular liver metastases: do unenhanced and hepatic arterial phase CT images affect tumor detection?
Oliver JH; Baron RL; Federle MP; Jones BC; Sheng R
Radiology; 1997 Dec; 205(3):709-15. PubMed ID: 9393525
[TBL] [Abstract][Full Text] [Related]
16. Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients.
Chambers TP; Baron RL; Lush RM
Radiology; 1994 Nov; 193(2):513-7. PubMed ID: 7972770
[TBL] [Abstract][Full Text] [Related]
17. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings.
Kuszyk BS; Bluemke DA; Urban BA; Choti MA; Hruban RH; Sitzmann JV; Fishman EK
AJR Am J Roentgenol; 1996 Jan; 166(1):91-5. PubMed ID: 8571914
[TBL] [Abstract][Full Text] [Related]
18. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases.
Leslie DF; Johnson CD; MacCarty RL; Ward EM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Dec; 165(6):1403-6. PubMed ID: 7484574
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols.
Leggett DA; Kelley BB; Bunce IH; Miles KA
Radiology; 1997 Dec; 205(3):716-20. PubMed ID: 9393526
[TBL] [Abstract][Full Text] [Related]
20. CT evaluation of suspected hepatic metastases: comparison of techniques for i.v. contrast enhancement.
Paushter DM; Zeman RK; Scheibler ML; Choyke PL; Jaffe MH; Clark LR
AJR Am J Roentgenol; 1989 Feb; 152(2):267-71. PubMed ID: 2783503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
